Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
JAMA Ophthalmology|March 25, 2016
Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular DegenerationGlenn L Stoller, Gregg T Kokame, Richard F Dreyer, et al.Experimental Eye Research|August 9, 2008
Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eyeJames S Swaney, Kelli M Moreno, Angela M Gentile, et al.Retina (Philadelphia, Pa.)|November 26, 2009
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%Jeffrey S Heier, Carl C Awh, Brandon G Busbee, et al.Developments in Ophthalmology|October 27, 2015
Future Perspectives: Agents on the HorizonJose R Maya, Mohammad Ali Sadiq, Aniruddha Agarwal, et al.Journal of Vitreoretinal Diseases|December 10, 2024
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular DegenerationJeffrey S Heier, Yingna Liu, Nancy M Holekamp, et al.Pageof 1